Mundo, Lucita R.
HRN: 07-15-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2025
CEFTAZIDIME 1GM (VIAL)
04/05/2025
04/11/2025
IVTT
1g
Q8
Complicated Urinary Tract Infection, Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes